109 related articles for article (PubMed ID: 6864504)
1. Aspects of the chemical stability of mitomycin and porfiromycin in acidic solution.
Underberg WJ; Lingeman H
J Pharm Sci; 1983 May; 72(5):549-53. PubMed ID: 6864504
[TBL] [Abstract][Full Text] [Related]
2. Determination of pKa values of some prototropic functions in mitomycin and porfiromycin.
Underberg WJ; Lingeman H
J Pharm Sci; 1983 May; 72(5):553-6. PubMed ID: 6306206
[No Abstract] [Full Text] [Related]
3. Effect of cyclodextrins on the chemical stability of mitomycins in alkaline solution.
Bekers O; Beijnen JH; Tank MJ; Bult A; Underberg WJ
J Pharm Biomed Anal; 1991; 9(10-12):1055-60. PubMed ID: 1822173
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and mechanism of the degradation of 1a-acetylmitomycin C in aqueous solution.
Underberg WJ; Beijnen JH
Pharm World Sci; 1993 Jun; 15(3):123-7. PubMed ID: 8348108
[TBL] [Abstract][Full Text] [Related]
5. Degradation kinetics and mechanism of N6-[(dimethylamino)methylene]mitomycin C in aqueous solutions.
Chen CM; Coppola WP; Johns WH; Bogardus JB; Lipper RA
J Pharm Sci; 1986 Feb; 75(2):208-10. PubMed ID: 3958935
[TBL] [Abstract][Full Text] [Related]
6. MITOMYCINS AND PORFIROMYCIN: CHEMICAL MECHANISM OF ACTIVATION AND CROSS-LINKING OF DNA.
IYER VN; SZYBALSKI W
Science; 1964 Jul; 145(3627):55-8. PubMed ID: 14162693
[TBL] [Abstract][Full Text] [Related]
7. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D
Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549
[TBL] [Abstract][Full Text] [Related]
8. Metabolites and DNA adduct formation from flavoenzyme-activated porfiromycin.
Pan SS; Iracki T
Mol Pharmacol; 1988 Aug; 34(2):223-8. PubMed ID: 3412325
[TBL] [Abstract][Full Text] [Related]
9. Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.
Fubara JO; Notari RE
J Pharm Sci; 1998 Dec; 87(12):1572-6. PubMed ID: 10189269
[TBL] [Abstract][Full Text] [Related]
10. 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function.
Na Y; Wang S; Kohn H
J Am Chem Soc; 2002 May; 124(17):4666-77. PubMed ID: 11971715
[TBL] [Abstract][Full Text] [Related]
11. Chemical stability of the antitumor drug mitomycin C in solutions for intravesical instillation.
Beijnen JH; van Gijn R; Underberg WJ
J Parenter Sci Technol; 1990; 44(6):332-5. PubMed ID: 2126037
[TBL] [Abstract][Full Text] [Related]
12. The effect of linoleic acid on pH inside sodium bis(2-ethylhexyl)sulfosuccinate reverse micelles in isooctane and on the enzymic activity of soybean lipoxygenase.
Rodakiewicz-Nowak J; Maślakiewicz P; Haber J
Eur J Biochem; 1996 Jun; 238(2):549-53. PubMed ID: 8681970
[TBL] [Abstract][Full Text] [Related]
13. Nefopam hydrochloride degradation kinetics in solution.
Tu YH; Wang DP; Allen LV
J Pharm Sci; 1990 Jan; 79(1):48-52. PubMed ID: 2313576
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
[TBL] [Abstract][Full Text] [Related]
15. Development of new mitomycin C and porfiromycin analogues.
Iyengar BS; Lin HJ; Cheng L; Remers WA; Bradner WT
J Med Chem; 1981 Aug; 24(8):975-81. PubMed ID: 7328599
[TBL] [Abstract][Full Text] [Related]
16. Decomposition of mitomycin and anthracycline cytostatics in cell culture media.
Beijnen JH; Van der Nat JM; Labadie RP; Underberg WJ
Anticancer Res; 1986; 6(1):39-43. PubMed ID: 3082277
[TBL] [Abstract][Full Text] [Related]
17. Degradation kinetics of metronidazole in solution.
Wang DP; Yeh MK
J Pharm Sci; 1993 Jan; 82(1):95-8. PubMed ID: 8429500
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
Fracasso PM; Sartorelli AC
Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
[TBL] [Abstract][Full Text] [Related]
19. PORFIROMYCIN.
DUVALL LR
Cancer Chemother Rep; 1963 Jul; 30():35-43. PubMed ID: 14051502
[No Abstract] [Full Text] [Related]
20. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
Keyes SR; Rockwell S; Sartorelli AC
Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
